X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

GNPX

Closed

Genprex Inc

0.267
+0.039 (+17.11%)
Last Update: 01 Jul 2025 23:25:00
Yesterday: 0.2279
Day's Range: 0.2205 - 0.267
Send
When Written:
 
0.8991
Genprex Inc is a clinical-stage gene therapy company that develops new therapies for cancer patients. The company's lead product candidate, Oncoprex, is a non-viral gene therapy that targets cancer cells and triggers programmed cell death. The company is also developing other gene therapies for lung cancer, including a combination therapy with Merck's Keytruda. Genprex was founded in 2009 and is headquartered in Austin, Texas. The company is listed on the NASDAQ exchange under the ticker symbol "GNPX".

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X